Researchers Resolved Structure of Bacterial Protein CdrA
The finding reveals how Pseudomonas aeruginosa builds biofilms, potentially informing new anti-biofilm drug design.
Updated on Sept. 18, 2026 in Life Sciences
Scientists have mapped the full-length structural conformation of CdrA, a protein used by Pseudomonas aeruginosa to anchor itself and form bacterial biofilms. This research identifies the specific molecular architecture behind bacterial surface attachment.
Why it matters
Understanding the mechanics of how bacteria aggregate is a critical step in developing therapeutics to prevent biofilm formation. This structural insight provides a roadmap for designing targeted interventions against the stubborn adhesions of Pseudomonas aeruginosa.
The CdrA protein structure was determined using cryo-electron microscopy—a technique that images samples frozen in a vitreous ice layer—and solid-state NMR for structural restraints. The resulting model reveals two distinct domains: an extension domain made of tandem repeats and an adhesive domain shaped like a claw.
The players
Pseudomonas aeruginosa
A common gram-negative bacterium known for its ability to form resilient biofilms and infect patients with compromised immune systems.
The details
The researchers combined cryo-electron microscopy and solid-state NMR—an analytical technique used to study molecular structure in solids—to generate the necessary data. They then utilized computational modeling to refine the full-length CdrA structure. The protein acts as a fibrillar adhesin, a proteinaceous fiber that allows bacteria to stick to surfaces or each other, facilitating the creation of protective biofilm colonies.
Timeline
September 18, 2026: The research findings were published in a peer-reviewed article.
The Tech Race
This mapping represents a critical advance in the broader race to decode how pathogens survive antibiotic treatments within protective biofilm matrices. By resolving the architecture of key adhesins, scientists are moving from broad-spectrum attacks toward highly specific inhibitors.
This research is currently in the fundamental discovery phase, meaning it does not yet change clinical treatment for infections. It serves as the prerequisite for future pharmaceutical development aimed at creating drugs that can dismantle bacterial defenses.
The takeaway
The resolution of the CdrA structure confirms the importance of tandem repeat modules in bacterial adhesion. Future research will likely focus on whether targeting these specific claw-like subdomains can successfully disrupt biofilm integrity in laboratory models.
Further reading
For more research on how pathogens adapt to their environments, see the latest developments in Life Sciences.
More information
Read the full results in the peer-reviewed research article.
Source note: This article includes information reported by Nature.
